iiinova — where your digital self keeps evolving

Simon Haas

@simonhaas.bsky.social

Professor at BIH@Charité, MDC and PHURI@QMUL

Simon Haas @simonhaas.bsky.social · 04/09/2026

1/4 🧬 New preprint from the lab! Can future clinical trajectories in AML already be read at diagnosis? We assembled single-cell multi-omics data from 184 AML patients across all known subtypes, linked to deep clinical outcome data. 🧵 www.biorxiv.org/content/10.6...

172

Simon Haas @simonhaas.bsky.social · 26/05/2026

In our new study, we identify stem cell kinetics and cellular competition as key principles underlying hematopoietic stem cell diversity. Fun collab@milsommick.bsky.social Florian Grünschläger@estherrodriguezc.bsky.social, Tamar Nizharadze, T. Höfer, D. Hübschmann(1/6) www.nature.com/articles/s41...

185

Simon Haas @simonhaas.bsky.social · 07/08/2025

Excited to share our latest paper @natmethods.nature.com We present a high-throughput framework to map cellular interactions at ultra-high scale – broadly applicable from whole-organism immune response mapping to personalized therapy response prediction (1/4). www.nature.com/articles/s41...

33514

Simon Haas @simonhaas.bsky.social · 08/02/2025

How does multiple myeloma progress? In our latest Science Immunology cover story, we reveal how myeloma cells breaking through bone trigger dangerous diversity. This arises from bidirectional interactions with the immune system, fueling disease evolution. scim.ag/4hMrLHs 1/2

2135